Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Debarment proceedings

Executive Summary

Former Vitarine VP and director of R&D Steven Colton permanently debarred by FDA via June 17 Federal Register notice. Colton was sentenced on Sept. 6, 1991 to 27 months in jail for three counts of making false statements to FDA concerning bioequivalence studies for Vitarine generic drug products. The purported generic versions of six brandname drugs submitted to an independent testing lab were the innovator products disguised.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS022808

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel